Technical Validation in Gate-All-Around
Measured silicon results demonstrate MST provides a significant improvement for a critical source strain liner application in gate-all-around (GAA) transistors versus an industry-standard diffusion-control approach. Atomera is actively running demonstrations with wafers from 2 target GAA customers and is in discussions with the other major GAA developers (TSMC, Samsung, Intel, Rapidus). Structural (TEM) analysis can ship back quickly; full electrical qualification may take ~6 months as customer fabs run the wafers.
Breakthrough in GaN on Silicon (RF & Power)
Preliminary data indicates MST can dramatically reduce the parasitic sheet charge at the GaN–silicon interface, potentially addressing a 20+-year industry problem. An industry veteran called the measured sheet-charge data the best he has seen in 20 years. Atomera is engaging on both 200 mm and 300 mm wafers and expanding GaN efforts from power into RF, which may enable faster commercial decisions.
Expanded Strategic and Ecosystem Partnerships
Expanded collaboration with a long-term strategic epi tool partner (weekly co-development), deeper engagement with Synopsys (MST modeling expanded into GaN workflows), and interactions with Incize, Texas State University, Sandia and others to accelerate technical validation and customer-translatable data.
Confirmed RF SOI and Power Device Progress
RF SOI technical results (power switch and LNA) have been confirmed through customer silicon runs. Development work shows potential for MST in TrenchFET and HVT transistors for high-frequency, high-speed and high-voltage applications. Wafers continue to move forward with a second JDA partner toward production pathways.
Significantly Strengthened Cash Position
Cash, cash equivalents and short-term investments increased to $41.1 million at 3/31/26 from $19.2 million at 12/31/25, an increase of $21.9 million (+114%). Financing included a $25.0 million registered direct offering (5.0M shares at $5; net proceeds $23.6M) and ~$3.2M via ATM sales (average $2.47). Current shares outstanding: 38.7M.
Operational Focus and 2026 Expense Guidance Maintained
Company reaffirmed 2026 annual non-GAAP operating expense guidance of ~$18.5 million and emphasized cost discipline. Non-GAAP operating expense for Q1 2026 was $4.8M, up modestly YoY as investment activity increased to support wafer runs and commercial work.